Main > GENETIC DISEASES (*) > USA. A. PH Type 1>Treat.>Lumasiran>

---

USA. A. PH Type 1>Treat.>Lumasiran>'s subsections
(*) EU CE Mark Date: 2020. 11.19
(*) USA Approval Date: 2020. 11.24
>for Inj.
Company
Endocrinology; Urology
Patent>Assignee; Claims; No.; Etc.
Patent>UpDate: 2021. 03.16
TradeMark
TradeMark Web-Site

USA. A. PH Type 1>Treat.>Lumasiran>'s products
This section has no products